Trey Paul is a CNET senior editor covering broadband. His 20+ years of experience as a writer and editor include time at CNET's sister site, Allconnect, and working with clients like Yahoo!
In addition to Trinamul Congress chairperson Mamata Banerjee and party’s national general secretary Abhishek Banerjee, Trinamul Congress today released names of party leaders, who will be star ...
Taiwanese infectious disease specialist TaiGen Biotechnology has announced positive results from a Phase III trial of TG-1000. Together with partner Joincare Pharmaceutical, the Taipei-based firm is ...
Applications are now open for Phase III of the Charleston Homes Program, which invites interested parties, including nonprofit organizations and private entities with experience in the production of ...
Discussions about improvements to that property are underway with the DNR for Phase III improvements. Whatever those will be, Sawyer said they will continue to be made with water-quality in mind, in ...
(RTTNews) - GSK plc. (GSK, GSK.L) announced positive results from the pivotal EAGLE-1 phase III trial for gepotidacin, a potential first-in-class oral antibiotic with a novel mechanism of action ...
A large areas of the country has seen above average this week, but cooler temperatures will be returning into the weekend. US Missile Expert Died from the Bends in High-Altitude Test Wendy's Is ...
Max & Josue discuss pressure mounting for Jayson Tatum & the No. 1 Celtics heading into their first-round playoff series and Mike Gorman Day at TD Garden, as the Voice of the Celtics is retiring ...
To promote the ability for consumers to access DirecTV without a satellite dish, the effort turns dishes into bird sanctuaries in a nod to the iconic moment when Johnson accidentally killed a bird ...
Robust top-line phase III data showed Intra-Cellular Therapies Inc.’s marketed oral atypical antipsychotic drug, Caplyta (lumateperone), achieved statistically significant and clinically meaningful ...
Intra-Cellular Therapies hopes to add another indication to its antipsychotic drug Caplyta (lumateperone), reporting positive Phase III data in major depressive disorder. The biopharma company’s stock ...